## LUAD MYC ChIP-seq - Mapping MYC Binding Sites in Lung Adenocarcinoma (A549)

# Overview

This project performs a complete ChIP-seq pipeline to identify genome-wide binding sites of the oncogenic transcription factor MYC in A549 lung adenocarcinoma (LUAD) cells.
Using ENCODE-matched replicates (2 MYC + 2 IgG controls), the analysis recovers:

- High-confidence MYC binding peaks

- Direct MYC-regulated oncogenes

- Key LUAD pathways controlled by MYC

- Peak annotation, motif enrichment, and pathway biology


# Biological Motivation

MYC is a master regulator of tumor growth. In LUAD, MYC drives:

- Ribosome biogenesis

- Protein synthesis

- Metabolic rewiring

- Cell-cycle progression

- Stress and survival signaling

# Goal

Identify where MYC binds the genome in A549 cells, and what biological programs MYC directly regulates.

# Data Summary

| Condition       | Replicate | SRA ID        | File Name            | Source Link                                                                              |
| --------------- | --------- | ------------- | -------------------- | ---------------------------------------------------------------------------------------- |
| **MYC ChIP**    | Rep 1     | **SRR568131** | `SRR568131.fastq.gz` | [https://www.ncbi.nlm.nih.gov/sra/SRR568131](https://www.ncbi.nlm.nih.gov/sra/SRR568131) |
| **MYC ChIP**    | Rep 2     | **SRR568132** | `SRR568132.fastq.gz` | [https://www.ncbi.nlm.nih.gov/sra/SRR568132](https://www.ncbi.nlm.nih.gov/sra/SRR568132) |
| **IgG Control** | Rep 1     | **SRR568133** | `SRR568133.fastq.gz` | [https://www.ncbi.nlm.nih.gov/sra/SRR568133](https://www.ncbi.nlm.nih.gov/sra/SRR568133) |
| **IgG Control** | Rep 2     | **SRR568134** | `SRR568134.fastq.gz` | [https://www.ncbi.nlm.nih.gov/sra/SRR568134](https://www.ncbi.nlm.nih.gov/sra/SRR568134) |


All datasets originate from a single ENCODE ChIP-seq experiment.

# Pipeline
1. QC (FastQC + MultiQC)

- Q-scores: 35‚Äì40 (excellent)

- GC content: ~41‚Äì43%

- Duplicate rate: low (4‚Äì18%)

- No adapters ‚Üí no trimming needed

2. Alignment (Bowtie2 ‚Üí hg38)

- 26‚Äì31 million reads per sample

- High alignment rate

- Sorted + indexed BAMs used for peak calling

3. Peak Calling (MACS2)
   
   'macs2 callpeak -t MYC.bam -c IgG.bam -g hs -f BAM -n MYC'

Results:

~5,000+ MYC peaks

Enrichment up to 40√ó

Summits used for motif analysis

4. Peak Annotation (ChIPseeker)

~50% promoter peaks

~935 MYC-bound genes

5. Enrichment Analysis (GSEApy + Enrichr)

GO: Biological Process

GO: Molecular Function

GO: Cellular Component

KEGG Pathways

6. Motif Analysis (HOMER)

Top enriched motif: MYC E-box (CACGTG)

üîç Example Figures
Genome-wide MYC Peak Distribution

MYC Binding at EGFR Promoter

üìä Key Results
üî• 1. Strong MYC binding at LUAD oncogenes
Gene	Fold Enrichment	Interpretation
EGFR	18.2√ó	Direct promoter binding ‚Üí growth signaling
FOSL1 (AP-1)	9√ó	Oncogenic transcription factor
TP53	8.6√ó	Stress & checkpoint regulation
HES4	5.7√ó	Notch pathway regulator
üî• 2. Genome-wide MYC activity

Peaks cluster around 4‚Äì6√ó enrichment

Long high-confidence tail up to 40√ó

Classic transcription factor ChIP-seq profile

üî• 3. GO Biological Process ‚Äî MYC drives biosynthesis

Top enriched biological processes:

Ribosome biogenesis

Translation

rRNA processing

Macromolecule biosynthesis

Peptide biosynthetic process

‚Üí MYC activates biosynthetic and proliferative programs.

üî• 4. GO Molecular Function

RNA binding

mRNA 5‚Ä≤-UTR binding

rRNA binding

snoRNA binding

Cadherin binding

‚Üí MYC regulates post-transcriptional control & adhesion.

üî• 5. GO Cellular Component

Nucleolus

Ribosomal subunits

Small-subunit processome

Focal adhesions

‚Üí MYC activates nucleolar, translational, and migration modules.

üî• 6. KEGG Pathway Enrichment

Most enriched pathways:

Ribosome (84 genes)

Ribosome biogenesis

RNA transport

Purine metabolism

PI3K/AKT & insulin signaling

Ferroptosis

Spliceosome

‚Üí MYC controls metabolic, proliferative, and stress-survival pathways.

üß† Final Biological Interpretation

In A549 LUAD cells, MYC directly binds and activates a multi-layer regulatory program that drives tumor progression.
MYC controls:

Growth signaling (EGFR, STAT3, FOSL1)

Cell-cycle progression (CDK4, CCND1, WEE1)

Metabolic rewiring (HK2, LDHA, FASN)

Ribosome & translation machinery (hundreds of RPL/RPS/EIF genes)

RNA processing & splicing

Ferroptosis regulators

Stress and DNA-repair programs

This represents a canonical, MYC-driven LUAD regulatory state.

üì¶ Repository Structure
LUAD_MYC_ChIPseq/
‚îÇ
‚îú‚îÄ‚îÄ peaks/
‚îú‚îÄ‚îÄ results/
‚îÇ   ‚îú‚îÄ‚îÄ annotated_peaks/
‚îÇ   ‚îú‚îÄ‚îÄ enrichment_results/
‚îÇ   ‚îú‚îÄ‚îÄ figures/
‚îú‚îÄ‚îÄ scripts/
‚îî‚îÄ‚îÄ README.md


(Large FASTQ/BAM files not included.)

üß† Skills Demonstrated
Bioinformatics

NGS QC & preprocessing

Bowtie2 alignment

MACS2 peak calling

ChIPseeker peak annotation

HOMER motif discovery

GO/KEGG enrichment analysis

Data visualization

Technical

Bash scripting

Python (pandas, matplotlib, gseapy)

Reproducible analysis

Git/GitHub workflow

Biology

Cancer genomics

MYC transcription factor biology

Lung adenocarcinoma pathways

Regulatory network interpretation

üìú License

Released under the MIT License.
